4//SEC Filing
Schwartz Daniel Mark 4
Accession 0000899243-21-031831
CIK 0001111485other
Filed
Aug 4, 8:00 PM ET
Accepted
Aug 5, 7:49 PM ET
Size
7.5 KB
Accession
0000899243-21-031831
Insider Transaction Report
Form 4
RxSight, Inc.RXST
Schwartz Daniel Mark
Director
Transactions
- Conversion
Series C Preferred Stock
2021-08-03−3,872→ 0 total→ Common Stock (3,969 underlying) - Conversion
Common Stock
2021-08-03+3,969→ 407,647 total
Footnotes (2)
- [F1]All shares of the Series C Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-1.0251 basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock.
- [F2]The number of shares reported as beneficially held by the Reporting Person in the Form 3 filed July 29, 2021 incorrectly overstated the number of shares held by 11,012 shares. The correct number of shares should have been reported as 403,678.
Documents
Issuer
RxSight, Inc.
CIK 0001111485
Entity typeother
Related Parties
1- filerCIK 0001874073
Filing Metadata
- Form type
- 4
- Filed
- Aug 4, 8:00 PM ET
- Accepted
- Aug 5, 7:49 PM ET
- Size
- 7.5 KB